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Abstract
Introduction We aimed to investigate whether the use of
aortic occlusion balloon (AOB) has an impact on mortality
of patients undergoing endovascular repair of ruptured
abdominal aortic aneurysms (RAAAs).
Methods A meta-analysis of the English-language litera-
ture was undertaken through February 2013. Articles
reporting data on outcome after endovascular repair of
RAAAs were identified and information regarding the use
of AOB was sought.
Results Included in this meta-analysis were 39 eligible
studies reporting 1277 patients. The pooled perioperative
mortality was 21.6 % (95 % CI 18.1–25.1 %). There was sig-
nificant within-study heterogeneity (I2 50.2 %, P\0.001). A
total of 200 patients required AOB with an estimated pooled
proportion of 14.1 % (8.9–19.3 %). Individual random-effects
meta-regression investigating the effect of AOB and other risk
factors on mortality revealed a significant linear association of
hemodynamic instability, bifurcated endograft approach, and
primary conversion to open repair with mortality and a non-
linear (second degree polynomial) association of AOB with
mortality. On multivariable meta-regression models, both
hemodynamic instability and AOB were found to be statisti-
cally significant, independent predictors of mortality. In par-
ticular, there was a statistically significant negative correlation
between AOB and mortality and a positive effect of hemody-
namic instability onmortality. In practical terms,mortality was
significantly higher in studies with a higher proportion of
hemodynamically unstable patients and lower in studies with a
higher rate of AOB use.
Conclusion This study provides meta-analytical evidence
that the use of an AOB in unstable RAAA patients
undergoing endovascular repair may improve the results.
Keywords Arterial intervention  Acute aortic
syndrome  Abdominal aortic aneurysms (AAA) 
Endovascular aneurysm  Repair/endovascular aortic
repair (EVAR)  Aorta
Introduction
Although endovascular repair (ER) of ruptured abdominal
aortic aneurysms (RAAAs) is an attractive option and
offers several theoretical advantages over open repair
(OR), there is still uncertainty whether the outcome of such
patients can be improved by endovascular surgery [1, 2].
Previous studies have shown that approximately one-third
of RAAA patients undergoing ER are hemodynamically
unstable and one in four experience complete circulatory
collapse [1, 3, 4]. Such cases require immediate proximal
occlusion of the aorta to control bleeding by rapidly
inflating a compliant aortic occlusion balloon (AOB).
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Maintaining balloon control continuously until the endo-
graft is fully deployed, and the rupture site excluded is
crucial for the survival. However, to date, there are no data
whether the introduction of AOB in hemodynamically
unstable patients positively influences the results. The aim
of this study was to investigate whether the use of AOB has
an impact on mortality of patients undergoing ER of
RAAAs by performing a meta-analysis and meta-regres-
sion analysis of previously published data.
Methods
This article was prepared according to previously pub-
lished guidelines for reporting meta-analyses of observa-
tional studies [5]. An English-language literature review
was carried out through February 2013 to examine the role
of AOB on mortality after ER of RAAAs.
Search Strategy
Two independent reviewers (CDK, CTP) performed the lit-
erature search. Disagreements were resolved by consensus.
Both the Medline and EMBASE databases were searched
using a combination of the following (MeSH/Emtree terms or
text words): (1) ‘‘Endovascular procedures’’ or ‘‘Endovascu-
lar Surgery’’ or ‘‘Endovascular Repair’’ or ‘‘Stents’’ or ‘‘Stent
Grafts’’ or ‘‘EVAR’’ and ‘‘Abdominal Aortic Aneurysm’’ or
‘‘Aortic Aneurysm, Abdominal’’ and ‘‘Rupture’’ or ‘‘Aortic
Rupture’’ or ‘‘AneurysmRupture’’; and (2) ‘‘AorticOcclusion
Balloon’’ and ‘‘Abdominal Aortic Aneurysm’’ or ‘‘Aortic
Aneurysm, Abdominal’’ and ‘‘Rupture’’ or ‘‘Aortic Rupture’’
or ‘‘Aneurysm Rupture’’. Both the ‘‘exp’’ (‘‘explode,’’ i.e., all
sub categorizations are included in the search) and ‘‘mp’’
(‘‘multipurpose search’’) tools were used http://site.ovid.com/
site/pdf/osp/basic_search_info_sheet.pdf). The electronic
search was supplemented by a manual search of the reference
lists of relevant articles and the abstract books of major
national vascular and general surgery meetings to ensure
inclusion of all possible studies and exclude duplicates.
Study Selection
All articles reporting data on outcome after ER of RAAAs
were identified and information regarding the AOB use was
collected. Only patients with true ruptures were included,
defined as those in whom extra-arterial extravasation of
blood or contrast had been demonstrated on preoperative
radiologic imaging. Those who underwent emergent ER of
an acute, symptomatic, nonruptured aneurysm were
excluded. Studies were also rejected if they described only
selected groups of patients (i.e., such as octogenarians), or
were single case reports. When studies reported duplicate
clinical material, the most recent study or the larger of the
two was selected.
Data Extraction
Data from eligible articles were abstracted into an Excel
spreadsheet (Microsoft Corp, Redmond, Wash). The primary
outcome measure was perioperative mortality, defined as all
‘‘perioperative,’’ ‘‘in-hospital,’’ and ‘‘30-day’’ mortality.
When information on both ‘‘in-hospital’’ and ‘‘30-day’’ mor-
tality was available, the latter was used for the analysis.
Additional data abstracted from each study were average age
of study population (mean or median); mid-time point of the
study (the date half-way through the study time period); type
of anesthesia (number of patients being operated on under
local anesthesia versus those being operated on under general,
or local converted to general anesthesia); hemodynamic
instability; endograft configuration (number of bifurcated vs
aortouniiliac and tube endografts); use of AOB; primary (i.e.,
intraoperative) conversion to OR; and the development of
abdominal compartment syndrome (ACS).
Statistical Analysis
A meta-analysis was performed to calculate the pooled
operative mortality after ER across published series. meta-
analysis is a statistical tool used to combine results of
independent studies to obtain a more precise estimate of
outcomes and to explore differences between study results.
Before such analysis can be performed, heterogeneity
between studies, which statistically tests the degree of
similarity between study outcomes, is usually determined.
If the heterogeneity is low, then ‘‘fixed-effects model’’
analysis should be used for data analysis, but if the
heterogeneity is high, the ‘‘random-effects model’’ is used
[6–8]. Heterogeneity across the studies was evaluated using
the I2 statistic, and random-effects models were used to
incorporate any heterogeneity present. An I2 value[50 %
has been considered to represent significant between-study-
heterogeneity and a ‘‘random-effects model’’ is used. The
latter is a statistical model in which both intra-study error
and inter-study variation are accounted for in the assess-
ment of uncertainty. meta-analysis was performed on a log
odds outcome scale, that is, a log [proportion/(1 - pro-
portion)] transformation. The log odds scale is used
because, unlike the probability scale, it is not bounded and,
thus, has more desirable statistical properties. Results were
transformed to the proportion scale to ease interpretability
and were expressed as pooled proportions (%) with 95 %
confidence intervals (CI). Publication bias was assessed by
visual inspection of funnel plots and quantified by the
Egger and the Begg tests. The Egger test tends to indicate
small study effects more frequently than the Begg test.
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To investigate the effect of AOB use and other risk factors
on mortality, a meta-regression analysis was subsequently
performed. In conventional statistical techniques, regression
is used to determine the effect of one factor upon an outcome
variable and a similar technique, called ‘‘meta-regression,’’
can be employed as part of a meta-analysis [8]. meta-re-
gression analyses (both linear and nonlinear) were per-
formed to explore the effect on mortality of the following 9
covariates: age, male gender, mid-time study point, local
anesthesia, hemodynamic instability, bifurcated approach,
balloon occlusion, primary conversion to OR, and ACS rate.
The individual and the combined effects of the covariates on
mortality had both been tested using separate single and
multiple meta-regression analyses. Correlation between the
covariates was also investigated, and amatrix of correlations
was created to inform the model-building process. Values in
matrix are between-1 and 1—values approaching either of
these are considered large correlations.
The level of significance was set at P\ 0.1. All statis-
tical analyses were carried out using Stata Statistical
Software 10.0 (Stata, College Station, TX, USA).
Results
Study Flow
A total of 89 articles on endovascular treatment of RAAAs
were identified and retrieved (Fig. 1). Twenty-seven were
excluded for one or more of the following reasons: 12 were
series from the same institutions with duplicate clinical
material; 7 were reviews or invited commentaries; one was a
study on octogenarians only; one was a study focused only on
patients transferred from other institutions; one was a study
which focused only on unstable patients with RAAAs and
excluded the stable ones; and, finally, 5 were single case
reports. Of the 62 remaining studies quoting figures on oper-
ative mortality after ER of RAAAs, 23 provided no infor-
mationwith regard to the use ofAOBandwere excluded. This
left 39 studies for the final analysis with data on 1277 patients
[9–47].
Meta-analysis
Basic details from individual studies are summarized in
Table 1. Information on gender was available in 30 studies;
81.6 % (CI 76.6–86.7 %) were men. The mean age was
74.8 years (CI 73.3–76.2). Of those with available information,
28.7 % (95 % CI 17–40.4 %) of patients had been operated
upon under local anesthesia; 55.9 % (95 % CI 42.0–69.8 %)
received a bifurcated endograft; 31.3 % (95 % CI
24.9–37.7 %) were hemodynamically unstable; 3.6 % (95 %
CI 1.8–5.4 %) of cases were converted intraoperatively to OR;
and 7.5 % (95 % CI 4.5–10.5 %) developed ACS post-
operatively.
A total of 288 patients died intraoperatively, during the
hospital stay or within 30 days, thus producing a pooled
perioperative mortality of 21.6 % (95 % CI 18.1–25.1 %)
(Fig. 2). There was significant within-study heterogeneity
(overall I2 = 50.2 %, P\ 0.001). Assessment of publica-
tion bias was performed by constructing a funnel plot
(Fig. 3). Even though in the left half of the triangle, the
distribution follows the funnel pattern, on the right-hand
side, which indicates higher level of mortality rates, the
scatter plot is concentrated to the upper corn of the triangle
and out of it. This can be considered as an indication of
small study bias. The Egger test failed to show small study
effects (P = 0.165), whereas the Begg’s rank correlation
showed evidence of bias (P = 0.010). Since the two quan-
titative tests for publication bias contradicted each other, the
upcoming results should be interpreted with caution.
Finally, with regard to theAOB, this was required in 200 out
of 1277patients across the 39 series, the pooled rate ofAOBuse
being 14.1 % (95 % CI 8.9–19.3 %). Again, there was signif-
icant within-study heterogeneity (I2 83.8 %, P\0.001).
Fig. 1 Flowchart of systematic review. ER endovascular repair, pts
patients, AOB aortic occlusion balloon
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Table 1 Study details
N First author, publication
year (country)
ER Mid-date
of study
Age Male LA Unstable
pts
Bifurcated
approach
Primary
conversion
to OR
ACS Operative
mortality
AOB
1 Greenberg, 2000
(USA, Sweden)
3 NA 82 1 0 2 0 0 0 0 2
2 Hinchliffe, 2001 (UK) 20 15 Jan 97 75 NA 0 4 0 3 NA 9 2
3 Veith, 2002 (USA) 25 15 Jan 98 NA NA 0 8 0 0 3 3 8
4 Yilmaz, 2002
(The Netherlands)
17 1 Sep 00 NA NA NA 12 NA 0 NA 4 0
5 Scharrer-Palmer, 2003
(Germany)
24 15 Jan 98 69 21 NA 4 19 1 0 5 0
6 Resch, 2003 (Sweden) 21 15 Oct 99 78 17 12 5 9 NA 1 4 5
7 Rubin, 2004 (USA) 5 1 Dec 00 72 4 4 0 5 1 0 1 0
8 Lee, 2004 (USA) 13 15 Aug 00 NA NA 1 0 13 0 NA 1 0
9 Lombardi, 2004 (USA) 5 1 Jan 02 NA NA 1 0 4 0 0 0 0
10 Alsac, 2005 (France) 17 15 Sep 02 72.9 16 1 1 8 3 1 4 1
11 Vaddineni, 2005 (USA) 9 1 Mar 02 70.8 7 0 0 9 0 NA 2 0
12 Lagana, 2006 (Italy) 30 1 Nov 02 76 27 0 9 25 0 1 3 3
13 Hinchliffe, 2006 (UK) 13 1 Nov 03 74 11 0 5 0 2 NA 7 0
14 Dalainas, 2006 (Italy) 20 1Jul 02 NA NA 20 NA 11 0 1 8 20
15 Pappelenbosch, 2005 (The
Netherlands, Belgium)
49 1 Dec 03 75.1 42 16 21 0 3 NA 17 3
16 Coppi, 2006 (Italy) 33 15 Feb 03 81 28 12 15 7 3 1 10 4
17 Moore, 2007 (USA) 20 1 Aug 03 NA NA 2 7 6 0 NA 1 7
18 Ockert, 2007 (Germany) 29 1 Jan 03 71 21 9 14 10 1 5 9 1
19 Najjar, 2007 (USA) 15 1 Jan 03 73 13 0 3 15 0 1 1 0
20 Anain, 2007 (USA) 30 1 Nov 03 NA NA 0 15 29 2 0 5 10
21 Lee, 2008 (USA) 17 15 Apr 04 NA 10 NA 8 NA 0 0 6 3
22 Karkos, 2008 (Greece) 41 1 Jan 02 73 39 27 21 27 0 1 17 2
23 Wibmer, 2008 (Austria) 16 15 Nov 04 76.05 12 NA 2 NA 0 3 4* 0
24 Sadat, 2009 (UK) 17 1 Jan 07 NA NA NA 0 NA NA NA 1 0
25 Holst, 2009 (Sweden) 90 15 Jan 04 76 77 45 55 50 0 3 24 23
26 Guo, 2009 (China) 26 15 Aug 02 68 20 5 10 20 0 1 6 4
27 Starnes, 2010 (USA) 27 1 Jun 08 NA 23 NA 18 NA 1 2 5 5
28 Delalieux, 2010 (Belgium) 9 1 Jul 07 73 9 NA 0 0 1 0 1 0
29 Knipp, 2010 (USA) 11 1 Oct 08 71 11 0 0 NA NA 2 2 0
30 Lyons, 2010 (UK) 18 1 Jan 07 76 18 NA NA 2 0 1 2 0
31 Hsiao, 2011 (Taiwan) 6 1 Dec 08 81 5 0 0 6 0 1 0 0
32 Djavani Gidlund, 2011 (Sweden) 32 1 May 07 72.5 26 29 8 32 0 3 4 2
33 Sarac, 2011 (USA) 32 15 May 04 80.5 21 17 2 18 NA 3 10 3
34 Carrafiello, 2012 (Italy) 42 15 May 04 77.9 33 NA 17 29 0 3 13 4
35 Noorani, 2012 (UK) 52 1 Sep 08 78 45 17 NA 19 NA 1 6 0
36 Nedeau, 2012 (USA) 19 1 Aug 05 78.2 14 0 9 19 0 0 3 2
37 Ioannidis, 2012 (Greece) 20 1 Jan 05 69.83 19 13 11 12 1 NA 10 1
38 Mayer, 2012 (Switzerland,
Sweden)
268 1 Jan 04 74.6 221 159 114 251 NA 64 48 62
39 Mehta, 2013 (USA) 136 1 Jul 06 73.67 94 0 44 NA 6 17 32 23
Studies appear in chronological order (publication year)
ER number of patients undergoing endovascular repair (ER), LA number of patients undergoing repair under local anesthesia (LA), pts patients,
OR open repair, ACS number of patients developing abdominal compartment syndrome (ACS), AOB aortic occlusion balloon, NA not available
* 90-day mortality figure quoted
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Meta-regression Analysis
The Effect of AOB Use and Other Risk Factors
on Mortality
A random-effects (linear) meta-regression was performed
to investigate the effect of AOB use and other risk factors
on mortality. Age, male gender, mid-time study point, local
anesthesia, hemodynamic instability, bifurcated approach,
balloon occlusion, primary conversion to OR, and ACS rate
were all included individually in separate meta-regressions
(Table 2). Of these, hemodynamic instability, a bifurcated
endograft approach, and primary conversion to OR had a
statistically significant linear association with death
Fig. 2 Forest plot (random-effects meta-analysis) for the mortality
figures in the 39 studies. Studies are ranked in chronological order
according to the mid-study year (i.e., the year half-way through the
study time period) which appears in parenthesis after the first author
name. The point estimate (black dot) and the 95 % CI (horizontal
line) for the mortality are plotted for each study. Each black dot is
surrounded by a gray box whose area represents the weight of the
study in the overall meta-analysis. The first number at the end of the
line for each study represents the estimate (ES), with the two numbers
in parenthesis indicating the 95 % CI. The relative weight given to
each study is provided to the far right of the plot as a percentage. The
pooled estimate for the meta-analysis is presented directly below the
estimates from the 39 studies and is represented as an ‘‘unfilled
diamond’’ with the center corresponding to the point estimate
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(Figs. 4, 5 and 6). With regard to the AOB, random-effect
meta-regression analysis failed to detect a significant linear
association between the use of AOB and mortality. How-
ever, when testing for a nonlinear (second degree polyno-
mial) correlation between the AOB use and the mortality
rate, balloon occlusion was significantly associated with
mortality (Fig. 7). In essence, studies with a higher pro-
portion of AOB use had, on average, a lower mortality.
Correlation Between the Meta-regression Variables
In addition to looking at each covariate individually, corre-
lation between the nine meta-regression covariates was also
investigated (Table 3). A strong correlation was observed
between ‘‘hemodynamic instability’’ and ‘‘AOB use.’’ This is
to be expected sincemost centers would opt for anAOB in the
presence of hemodynamic instability. A significant positive
correlation was also indicated between the ‘‘age’’ and ‘‘AOB
use,’’ suggesting a higher likelihood for AOB use in older
patients. Finally, no significant correlation could be found
between ‘‘AOB use’’ and ‘‘mid-study year,’’ indicating that
the balloon use did not change significantly over time.
Multivariate Meta-regression Testing
The combined effect of the above 9 covariates onmortality had
been tested using a multivariable meta-regression analysis
model, but none proved to be statistically significant (Table 4).
To investigate this further, we created multiple models
including different combinations of clinically or statistically
significant covariates (hemodynamic instability, AOB, bifur-
cated approach, primary conversion toOR, andACS). The aim
was to assess the effects of AOB on mortality after correcting
for the effects of other covariates within a study.
To this extent, three further multivariate models had been
created incorporating five, four, and two covariates of interest,
respectively (Tables 5, 6, and 7). All three models produced
similar results in that both hemodynamic instability and AOB
were found to be statistically significant, independent pre-
dictors of mortality. In particular, there was a statistically
significant negative correlation between AOB and mortality
and a positive effect of hemodynamic instability onmortality.
In practical terms,mortalitywas significantly higher in studies
with a higher proportion of hemodynamically unstable
patients, and lower in studies with a higher rate of AOB use.
Apart from hemodynamic instability and AOB, the
remaining covariates which had been included in the
models (i.e., bifurcated approach, primary conversion to
OR, and ACS) were not found to be statistically significant.
However, the probability in all three models is \5 %,
Fig. 3 Funnel plot assessment of publication bias across the 39
studies. The mortality (log odds ratio) is plotted on the x-axis and the
standard error (SE) of mortality (log odds ratio) is plotted on the y-
axis. Visual interpretation of the plot suggests the possibility of small
study bias
Table 2 Summary of individual meta-regressions with mortality
Covariate Studies
(No)
Pts with covariate/
total pts (No)
Pooled estimate
(95 % CI)
Slope
coefficient
SE P
Age 29 1086/1086 74.8 years (73.3–76.2) -0.019 0.349 0.581
Male gender 30 905/1110 81.6 % (76.6–86.7 %) -0.276 1.096 0.802
Mid-study year 38 1274/1274 2003 (2002–2004) -0.060 0.397 0.139
Local anesthesia 30 390/1090 28.7 % (17.0–40.4 %) 0.590 0.417 0.168
Hemodynamic instability 36 444/1187 31.3 % (24.9–37.7 %) 0.952 0.554 0.095*
Bifurcated endograft configuration 32 655/1036 55.9 % (42.0–69.8 %) -0.733 0.353 0.047*
Use of AOB 39 200/1277 14.1 % (8.9–19.3 %) 0.290 0.581 0.620
Conversion to OR 33 28/876 3.6 % (1.8–5.4) 3.980 2.159 0.075*
ACS 30 119/1099 7.5 % (4.5–10.5 %) -0.979 1.260 0.443
Of the 9 covariates, only hemodynamic instability, a bifurcated endograft approach, and primary conversion to OR had a statistically significant
linear association with death
No number, Pts patients, CI confidence interval, SE standard error, AOB aortic occlusion balloon, OR open repair, ACS abdominal compartment
syndrome
* P\ 0.1 significance level
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indicating that all included covariates are jointly signifi-
cant. Based on the F statistic, the last model (hemodynamic
instability-AOB) has the highest statistical power.
Discussion
Survival of a patient with RAAA depends, at large, on how
quickly an aortic cross-clamp can be applied and OR
completed. A similar principle applies for the ER, i.e.,
achieving endovascular exclusion of the aneurysm and
Fig. 4 Meta-regression bubble plot of hemodynamic instability (on
x-axis) against operative mortality (log odds scale on y-axis). Circles
represent individual studies; the size of the circle is proportional to the
inverse of the variance of the mortality estimate for that study,
indicating the relative influence in the meta-analysis. The plot
suggests that series with a higher proportion of unstable patients had
on average a higher mortality
Fig. 5 Meta-regression bubble plot of bifurcated endograft approach
(on the x-axis) against mortality (log odds scale on y-axis). The plot
indicates that a bifurcated endograft approach is associated with a
statistically significant reduction in the mortality. In practical terms,
centers performing a higher proportion of bifurcated (vs aortouniiliac)
endografts are likely to achieve better results
Fig. 6 Meta-regression bubble plot of primary conversion to OR
(x-axis) versus mortality (log odds ratio on y-axis). This shows a
significantly higher chance of dying when primary (intraoperative)
conversion to OR was necessary
Fig. 7 Meta-regression plots of balloon occlusion versus mortality.
There is no significant linear association between the use of AOB and
mortality (A). However, a significant nonlinear (second degree
polynomial) correlation between the AOB use and the mortality rate
could be demonstrated (B)
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Table 3 Matrix of correlations between the 9 meta-regression covariates
Mid-study
year
Age Male Bifurcated
endograft
Hemodynamic
instability
Conversion
to OR
ACS AOB
use
LA
Mid-study year 1.00
Age 0.22 1.00
Male 0.16 -0.42 1.00
Bifurcated endograft 0.07 -0.24 0.04 1.00
Hemodynamic instability 0.00 0.17 -0.31 -0.28 1.00
Conversion to OR -0.21 -0.16 0.26 -0.29 -0.25 1.00
ACS 0.26 -0.06 0.07 0.09 -0.16 -0.22 1.00
AOB use -0.16 0.42 -0.70 -0.18 0.52 -0.21 -0.12 1.00
LA 0.04 -0.12 0.16 0.14 0.13 0.03 -0.04 0.24 1.00
Values in matrix range between -1 and 1 with those approaching either of these being considered large correlations
OR open repair, ACS abdominal compartment syndrome, AOB aortic occlusion balloon, LA local anesthesia
Table 4 The combined effect
of 9 covariates on mortality
Log odds ratio Coefficient SE t P 95 % CI
Mid-study time point 0.0743 0.2242 0.33 0.772 -0.8905 1.0391
Age -0.0916 0.0828 -1.11 0.384 -0.4479 0.2646
Male 1.5913 2.9232 0.54 0.641 -10.9863 14.1690
Bifurcated approach -1.0763 1.8226 -0.59 0.615 -8.9184 6.7658
Hemodynamic instability 3.4823 2.8443 1.22 0.345 -8.7557 15.7204
Primary conversion to OR 5.1657 7.9094 0.65 0.581 -28.8659 39.1973
ACS -4.5035 7.4519 -0.60 0.607 -36.5664 27.5595
AOB -3.4384 2.7548 -1.25 0.338 -15.2915 8.4146
LA 0.1835 0.8376 0.22 0.847 -3.4207 3.7877
Constant -144.9255 444.0717 -0.33 0.775 -2055.612 1765.761
Key SE standard error, 95 % CI 95 % confidence interval, OR open repair, ACS abdominal compartment
syndrome, AOB aortic occlusion balloon, LA local anesthesia
Results of random-effects multiple meta-regression analysis. Number of studies: 12; method of moments
estimate of between-study variance tau2 = 0.0385; % residual variation due heterogeneity I2 = 0.00 %;
proportion of between-study variance explained: adjusted R2 = 100.00 %; joint test for all covariates:
model F (9, 2) = 1.69; with Knapp-Hartung modification P[F = 0.4264
Table 5 The combined effect
of 5 covariates on mortality
Log odds ratio Coefficient SE t P 95 % CI
Hemodynamic instability 3.2275 0.9817 3.29 0.006 1.1066 5.3483
AOB -3.5897 1.2842 -2.80 0.015 -6.3641 -0.8153
ACS -1.5566 2.8131 -0.55 0.589 -7.6339 4.5207
Bifurcated approach -0.4478 0.5346 -0.84 0.417 -1.6026 0.7071
Primary conversion to OR 2.7706 3.1581 0.88 0.396 -4.0519 9.5932
Constant -1.7342 0.7217 -2.40 0.032 -3.2933 -0.1750
Key SE standard error, 95 % CI 95 % confidence interval, AOB aortic occlusion balloon, ACS abdominal
compartment syndrome, OR open repair
Results of random-effects multiple meta-regression analysis. Number of studies: 19; tau2 = 0; % residual
variation due heterogeneity I2 = 0 %; proportion of between-study variance explained: adjusted
R2 = 100 %; joint test for all covariates: model F (5, 13) = 3.03; with Knapp-Hartung modification
P[F = 0.0497
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sealing the rupture site as quickly as possible. In those who
present with circulatory collapse, in particular, this process
needs to be carried out instantly. Because of the logistical
delays associated with an endovascular RAAA service, ER
was initially considered as a contraindication for RAAA
patients. As result, ER was only offered in stable patients
with a contained hematoma who were able to tolerate such
delays. Gradually, there was a shift towards taking on
unstable patients too. Proximal aortic control in unstable
patients can be achieved by inflating an AOB at the level of
the descending aorta. However, the benefit of this maneu-
ver has yet to be proven. Since no previous study investi-
gated this issue, such evidence could be derived by meta-
analyzing the existing relevant literature. The present study
is the first to address this issue.
Proximal aortic control during emergency ER can be
achieved by an AOB using either a transbrachial
(transaxillary) or a transfemoral approach [11, 48–51].
Each has pros and cons. A brachial approach is theoreti-
cally simpler, decreases manipulation within the aortic sac
and prevents distal migration of the balloon [48–51].
However, percutaneous brachial or axillary puncture is
difficult in the hypotensive patient—risking injury to the
smaller upper limb arteries, and therefore, time-consuming
surgical exposure of the artery may be necessary. Damage
to peripheral nerves, e.g., median nerve, is another poten-
tial complication of the transbrachial approach. Further-
more, descending aortic catheterization from either arm is
associated with the risk of stroke due manipulation within
in the aortic arch and interferes with the positioning of the
C-arm [49]. Moreover, large balloon catheters require 14-F
introducer sheaths that are difficult or impossible to pass
from either arm. One of the advantages of the transfemoral
technique is that it minimizes renal and visceral ischemia,
both of which are associated with poorer outcomes.
Nowadays, the transfemoral approach has been refined
with the use of a dual balloon technique and is favored by
the majority of interventionists [48, 49]. This is accom-
plished with a sheath-supported AOB inserted via the groin
contralateral to the side to be used for insertion of the
endograft main body. After the main body is fully
deployed, a second balloon is placed within the endograft,
and the first balloon is removed, so that extension limbs
can be placed in the contralateral side. The first balloon can
then be re-introduced via the contralateral side and inflated,
so that ipsilateral extensions could be deployed as neces-
sary [49]. This step-by-step technique shortens the time of
visceral ischemia without necessitating repeat declamping
until the aneurysm has been completely excluded.
The present study shows that the use of AOB does
appear to have a beneficial effect on mortality. In partic-
ular, mortality was on average significantly higher in
studies with a higher proportion of hemodynamically
unstable patients and lower in studies with a higher rate of
AOB use. This is something to be expected and backs the
use of AOB as an important adjunct in unstable RAAA
Table 6 The combined effect
of 4 covariates on mortality:
results of random-effects
multiple meta-regression
analysis
Log odds ratio Coefficient SE t P 95 % CI
Hemodynamic instability 1.5765 0.6545 2.41 0.028 0.1958 2.9573
AOB -2.5239 1.0864 -2.32 0.033 -4.8161 -0.2317
ACS -0.2029 1.1071 -0.18 0.857 -2.5388 2.1329
Bifurcated approach -0.6048 0.3808 -1.59 0.131 -1.4081 0.1985
Constant -1.0056 0.3432 -2.93 0.009 -1.7297 -0.2815
Key SE standard error, 95 % CI 95 % confidence interval, AOB aortic occlusion balloon, ACS abdominal
compartment syndrome
Number of studies: 22; method of moments estimate of between-study variance tau2 = 0; % residual
variation due heterogeneity I2 = 0 %; proportion of between-study variance explained: adjusted
R2 = 100 %; joint test for all covariates: model F (4, 17) = 3.41; with Knapp-Hartung modification
P[F = 0.0321
Table 7 The combined effect
of 2 covariates on mortality:
Results of random-effects
multiple meta-regression
analysis
Log odds ratio Coefficient SE t P 95 % CI
Hemodynamic instability 1.4654 0.5329 2.75 0.010 0.3810 2.5497
AOB -2.8703 0.9449 -3.04 0.005 -4.7928 -0.9478
Constant -1.2847 0.2109 -6.09 0.000 -1.7139 -0.8556
Key SE standard error, AOB aortic occlusion balloon
Number of studies: 36; method of moments estimate of between-study variance tau2 = 0.0385; % residual
variation due heterogeneity I2 = 16.16 %; proportion of between-study variance explained: adjusted
R2 = 68.51 %; joint test for all covariates: model F (2, 33) = 6.11; with Knapp-Hartung modification
P[F = 0.0055
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patients undergoing ER. Other important factors that may
jointly impact on the results included a bifurcated endo-
graft approach, the need for conversion to OR intraopera-
tively, and the post-operative development of ACS. This
lower mortality with the use of bifurcated endografts (as
opposed to aortouniiliac configuration) has been confirmed
by experienced centers and systematic reviews [2, 4, 52,
53]. Similarly, the higher mortality encountered when the
patient is converted to OR intraoperatively or in case of
ACS is line with previously published studies [4, 52–54].
With regard to the level of evidence and the quality of
pooled studies, therewas only one randomized controlled trial
(RCT) identified during the study period and included in the
meta-analysis. Thiswas theNottinghamRCTwhich recruited
13 patients in the endovascular arm and reported a 53 %
mortality rate [21]. There was also a large joint experience on
268 patients—by far the largest in the pooled series—from
two pioneering centers in Zurich, Switzerland and O¨rebro,
Sweden [46]. The majority of the remaining studies were
mostly retrospective, single-center case series. Two important
RCTs have been published since, the UK IMPROVE and the
Amsterdam Acute Aneurysm trials [2, 55, 56]. These two
large multicenter, high-quality studies represent the best
evidence so far on the ER for RAAAs. Although our intention
was to extend the time period of the meta-analysis to the
present date to incorporate these two RCTs, we were disap-
pointed for not being able to do so, since they provided no
useable information on AOB. The IMPROVE provided no
data on AOB use [2, 55], whereas the Amsterdam trial did
report AOB use in 4 of the 57 patients randomized to ER;
however, accurate data could not be extracted since this group
included amixture of patients, i.e., 2 crossover before surgery;
8 conversions toOR (access failure in 3, persistent endoleak in
5); and 1 death during ER [56]. Finally, another important
study onAOB, which cannot be included in the meta-analysis
either, is the one published recently by the Henri Mondor
group, Creteil, France [57]. This single-center retrospective
study focused only on hemodynamically unstable patients
undergoing open or ER and received conventional aortic
cross-clamping or AOB. Compared with conventional aortic
cross-clamping, AOB was found to be associated with
reduced intraoperative mortality of unstable RAAA patients
but not in-hospital mortality.
Unfortunately, this study has certain other limitations
which have to be stressed. The combined studies had many
inconsistencies in the reporting, were heterogeneous, suffer
from small numbers, and seem to be influenced by several
selection biases. Of the 62 potentially eligible studies
(quoting figures on operative mortality after ER of
RAAAs), 23 provided no information with regard to the
use of AOB and were excluded. This left out a wealth of
useful data, which is a weakness. Also, covariates were not
available for a proportion of studies, and, as a result, the
eligible sample size was considerably reduced. Addition-
ally, a multivariable meta-regression model investigating
the correlation between several covariates is associated
with a large degree of uncertainty because large numbers of
hypothesis tests are being done. Therefore, caution is
always needed in drawing conclusions based on such a
multivariable model. Another important point is that not all
patients had a uniform AOB technique despite having been
pooled together. Some surgeons preferred the transbrachial
approach, whereas others used the transfemoral one. Fur-
thermore, included studies differed considerably with
regard to what constitutes hemodynamic instability and the
criteria for balloon occlusion. Finally, the pooled studies
span a long period of time during which significant pro-
gress was made, including an increasing endovascular
experience with RAAAs and the use of newer generation
endografts. Despite the above, this study, using advanced
statistical tools and achieving maximal utilization of the
present dataset, provides unique evidence on the AOB use
rate across the collected world experience as well as its
possible impact on mortality.
Insertion of an AOB requires an additional step in the
endovascular procedure that may consume precious time.
As a result, in the earlier years of endovascular RAAA
repair literature, several authors favored expeditious
endograft deployment without the use of occlusion bal-
loons [3, 10, 12, 58]. Nevertheless, nowadays, most would
agree that, when well rehearsed and smoothly performed
by the endovascular team, AOB is a significant adjunct
which benefits endovascular RAAA repair patients [48,
49]. It is important to emphasize that the use of AOB is
only one of the links of the complex chain of the
endovascular management of RAAAs. There are several
other key strategies, adjuncts, and technical factors that are
crucial in achieving favorable outcomes in this population,
including the implementation of a standardized approach,
team experience, hypotensive hemostasis, use of local
anesthesia, and, last but not least, early recognition and
treatment of ACS. Finally, it is likely that there will never
be a definitive proof of the superiority of AOB use (vs no
AOB) in unstable patients because such a study would be
unethical to conduct. This is a situation not dissimilar to the
introduction of cerebral protection devices during carotid
artery stenting. Such devices became the standard of care
despite that no prospective study ever compared protected
versus unprotected carotid stenting.
Conclusion
AOB can be used for instant endovascular clamping of the
aorta in patients undergoing emergency ER of RAAAs.
The estimated utilization rate of AOB across the pooled
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population was 14 %. The present study also provides
meta-analytical evidence that the use of an AOB in
unstable RAAA patients undergoing ER may improve the
results. Further studies will be needed to clarify this issue
and promote a more widespread use of the technique
among the endovascular specialists.
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